BETAHISTINE-ZP betahistine dihydrochloride 8mg tablets blister pack

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

betahistine dihydrochloride, Quantity: 8 mg

Available from:

Medis Pharma Pty Ltd

INN (International Name):

betahistine dihydrochloride

Pharmaceutical form:

Tablet

Composition:

Excipient Ingredients: stearic acid; crospovidone; colloidal anhydrous silica; povidone; lactose monohydrate; microcrystalline cellulose

Administration route:

Oral

Units in package:

100 tablets, 10 tablets, 25 tablets

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

Meniere?s Syndrome as defined by the following core symptoms: ,- vertigo (with nausea/vomiting) ,- hearing loss (hardness of hearing) ,- tinnitus

Product summary:

Visual Identification: White to almost white, round, flat bevelled edged tablets embossed B8 on one side and scored on the other; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

Authorization status:

Licence status A

Authorization date:

2015-11-10